Evidence map›Paper›PMID 39966630›Full record

ArticleCommunications biology2025

Capsule mutations serve as a key strategy of phage resistance evolution of K54 hypervirulent Klebsiella pneumoniae.

Yu Fu, Ming Yin, Li Cao, Yanjun Lu, Ying Li, Luhua Zhang

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Antimicrobial agents and chemotherapy · 2026
    Article
  12. Review
  13. Host-dependent effects ofFrontiers in microbiology · 2026
    Article
  14. Novel bacteriophages effectively target multidrug-resistant clinical isolates of Klebsiella pneumoniae.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  15. Within-host adaptation mutations associated with persistent colonization ofFrontiers in cellular and infection microbiology · 2026
    Article
  16. Phage P100 resistance in clinical and foodborneCurrent research in microbial sciences · 2026
    Article
  17. Phage and endolysin-based inhibition ofFrontiers in cellular and infection microbiology · 2026
    Review
  18. Article
  19. Article
  20. Predictors of mortality and progression from colonization to Stenotrophomonas maltophilia bloodstream infection in hematologic disorders: a single-center retrospective study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yu Fu *The School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan, China.
Ming Yin *The School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan, China.
Li CaoThe School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan, China.
Yanjun LuThe School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan, China.
Ying LiThe School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan, China. Lying1019@swmu.edu.cn.ORCID http://orcid.org/0009-0007-6988-2688
Luhua ZhangThe School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan, China. zhluhua@swmu.edu.cn.ORCID http://orcid.org/0000-0001-6458-3530

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82302576
6 · The paper itself

Abstract

Phage therapy is a promising antibacterial strategy against the antibiotic resistance crisis. The evolved phage resistance could pose a big challenge to clinical phage therapy. Therefore, it is necessary to conduct a comprehensive analysis of phage resistance mechanisms during treatment. Here, we characterize 37 phage-resistant mutants of hypervirulent K. pneumoniae strain SCNJ1 under phage-imposed selection in both in vitro and in vivo experiments. We show that 97.3% (36/37) of phage-resistant clones possessed at least one mutation in genes related to the CPS biosynthesis. Notably, the wcaJ gene emerges as a mutation hotspot, as mutations in this gene are detected at a high frequency under both conditions. In contrast, mutations in wzc exhibit more association with in vivo samples. These CPS-related mutants all exhibit compromised bacterial fitness and attenuated virulence in mice. Strain CM8 is the only non-CPS-related mutant, which has a bglA mutation that confers phage resistance and retains full fitness and virulence. This study highlights that laboratory characterization of phage resistance evolution can give useful insights for clinical phage therapy.

Indexed as

Bacterial CapsulesBacteriophagesKlebsiella InfectionsKlebsiella pneumoniaeMutationAnimalsEvolution, MolecularFemaleMicePhage TherapyVirulence

Identifiers

PMID39966630
PMCPMC11836320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.